1. Home
  2. DLXY vs VVOS Comparison

DLXY vs VVOS Comparison

Compare DLXY & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DLXY

Delixy Holdings Limited Ordinary Shares

N/A

Current Price

$0.91

Market Cap

14.9M

Sector

N/A

ML Signal

N/A

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.50

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLXY
VVOS
Founded
2007
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9M
17.7M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
DLXY
VVOS
Price
$0.91
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
59.3K
131.2K
Earning Date
03-13-2026
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
1077.13
N/A
EPS
0.08
N/A
Revenue
$273,155,000.00
$17,317,000.00
Revenue This Year
N/A
$28.86
Revenue Next Year
N/A
$48.70
P/E Ratio
$14.37
N/A
Revenue Growth
N/A
18.76
52 Week Low
$0.61
$1.46
52 Week High
$7.16
$7.95

Technical Indicators

Market Signals
Indicator
DLXY
VVOS
Relative Strength Index (RSI) 49.55 28.96
Support Level $0.82 $1.67
Resistance Level $1.12 $1.66
Average True Range (ATR) 0.13 0.14
MACD 0.02 -0.04
Stochastic Oscillator 32.81 9.45

Price Performance

Historical Comparison
DLXY
VVOS

About DLXY Delixy Holdings Limited Ordinary Shares

Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: